Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Dermatol Surg ; 47(1): 61-64, 2021 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-32371783

RESUMEN

BACKGROUND: Raynaud's phenomenon (RP) is a clinical syndrome characterized by recurrent episodes of digital vasospasm triggered by exposure to physical and chemical agents or emotional stress. Although many pharmacologic treatments have been tested, there is still no cure or gold standard therapy. Botulinum toxin treatment has been proved to reduce pain and increase arterial blood flow in treated hands of adult patients with RP. OBJECTIVE: The aim of this study is to evaluate the efficacy of botulinum toxin A on younger than 18-year-old patients with primary and secondary RP. MATERIALS AND METHODS: A single-center prospective study was performed, including 8 patients aged 14 to 17 years who were clinically diagnosed with primary or secondary RP. BTX was injected into each hand without sedation or anesthetic blockade. The primary outcome was pain reduction after BTX injection. Pain intensity was evaluated at baseline and in the first follow-up. Secondary outcomes included variations in the number and severity of RP episodes after the BTX injection. RESULTS: All patients stated significant pain reduction and decreased cold sensitivity, except one patient who did not feel any changes. No patients reported any loss of strength on thumb-index finger. CONCLUSION: BTX injection is a simple, noninvasive, and cost-effective treatment alternative, offering an important nonsurgical therapeutic option for the pediatric population. It could also help optimize the dose of other treatments used in these patients. The most commonly observed positive effect is a reduction in the pain associated with RP attacks. Further studies are needed to confirm these results.


Asunto(s)
Toxinas Botulínicas Tipo A/uso terapéutico , Fármacos Neuromusculares/uso terapéutico , Enfermedad de Raynaud/tratamiento farmacológico , Adolescente , Toxinas Botulínicas Tipo A/administración & dosificación , Femenino , Humanos , Inyecciones , Masculino , Fármacos Neuromusculares/administración & dosificación , Manejo del Dolor , Dimensión del Dolor , Estudios Prospectivos
2.
Pediatr Dermatol ; 37(6): 1131-1134, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32777110

RESUMEN

Dyskeratosis congenita (DC) is an unusual inherited disease characterized by the triad of mucosal leukoplakia, nail dystrophy, and skin pigmentation. Hyperkeratosis of the palms and soles is another reported skin finding. This hyperkeratosis can lead to fissures, chronic erosion, and deep ulcerations. These atypical wounds are not only a diagnostic but a therapeutic challenge for clinicians, and there are no standardized treatments for these types of chronic wounds. Punch grafting is a traditional and minimally invasive technique to enhance wound healing, and it has been associated with significant and quick pain reduction in ulcers with various underlying causes. Herein, we describe a patient with DC with a chronic and refractory plantar ulcer successfully treated with punch grafting.


Asunto(s)
Disqueratosis Congénita , Procedimientos de Cirugía Plástica , Niño , Disqueratosis Congénita/complicaciones , Humanos , Microcirugia , Úlcera , Cicatrización de Heridas
3.
Pediatr Dermatol ; 37(4): 681-683, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32212180

RESUMEN

Raynaud's phenomenon (RP) is an episodic vasospastic response to cold or emotional stress causing color changes and pain. These attacks can lead to digital ischemia, ulcers, and gangrene. Severe and refractory RP in children is a therapeutic challenge for clinicians because there are no standardized treatment protocols for these patients. We present a case of RP involving the toes of a child successfully treated with botulinum toxin A.


Asunto(s)
Toxinas Botulínicas Tipo A , Enfermedad de Raynaud , Niño , Humanos , Dolor , Enfermedad de Raynaud/tratamiento farmacológico , Enfermedad de Raynaud/etiología , Dedos del Pie , Úlcera
4.
Pediatr Dermatol ; 37(3): 517-519, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32045494

RESUMEN

Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare, severe, and recently described multisystem developmental disorder characterized by delayed psychomotor development and intellectual disability, characteristic facial features, hypotonia, poor overall growth, and visual abnormalities. Mucocutaneous manifestations have not been reported so far among individuals with ZTTK syndrome. Herein, we present a patient with ZTTK syndrome due to a de novo mutation in SON gene, who has dental abnormalities and retronychia of the toenails. We suggest that mucocutaneous features may be a part of the phenotype.


Asunto(s)
Discapacidad Intelectual , Uñas Malformadas , Humanos , Discapacidad Intelectual/genética , Mutación , Uñas , Uñas Malformadas/genética , Fenotipo
5.
Indian J Dermatol ; 60(4): 423, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26288449

RESUMEN

Cirsoid aneurysm is a small vascular proliferation characterized by small to medium-sized channels with features of arteries and veins, that present as small, blue or red asymptomatic papule. We report a case of a crisoid aneurysm on the forhead of an HIV patient that suggested a Kaposi sarcoma as a differential diagnosis.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...